Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice

268Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

Advanced glycation end products (AGEs) and their cell surface receptor, RAGE, have been implicated in the pathogenesis of diabetic complications. Here, we studied the role of RAGE and expression of its proinflammatory ligands, EN-RAGEs (S100/calgranulins), in inflammatory events mediating cellular activation in diabetic tissue. Apolipoprotein E-null mice were rendered diabetic with streptozotocin at 6 weeks of age. Compared with nondiabetic aortas and kidneys, diabetic aortas and kidneys displayed increased expression of RAGE, EN-RAGEs, and 2 key markers of vascular inflammation, vascular cell adhesion molecule (VCAM)-1 and tissue factor. Administration of soluble RAGE, the extracellular domain of the receptor, or vehicle to diabetic mice for 6 weeks suppressed levels of VCAM-1 and tissue factor in the aorta, in parallel with decreased expression of RAGE and EN-RAGEs. Diabetic kidney demonstrated increased numbers of EN-RAGE-expressing inflammatory cells infiltrating the glomerulus and enhanced mRNA for transforming growth factor-β, fibronectin, and α1 (IV) collagen. In mice treated with soluble RAGE, the numbers of infiltrating inflammatory cells and mRNA levels for these glomerular cytokines and components of extracellular matrix were decreased. These data suggest that activation of RAGE primes cells targeted for perturbation in diabetic tissues by the induction of proinflammatory mediators.

References Powered by Scopus

Diabetes and Cardiovascular Disease: The Framingham Study

3892Citations
N/AReaders
Get full text

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1959Citations
N/AReaders
Get full text

RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides

1700Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cytokines in atherosclerosis: Pathogenic and regulatory pathways

1463Citations
N/AReaders
Get full text

Mechanisms, pathophysiology, and therapy of arterial stiffness

1457Citations
N/AReaders
Get full text

Understanding RAGE, the receptor for advanced glycation end products

1118Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kislinger, T., Tanji, N., Wendt, T., Qu, W., Lu, Y., Ferran, L. J., … Schmidt, A. M. (2001). Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 21(6), 905–910. https://doi.org/10.1161/01.ATV.21.6.905

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 21

58%

Researcher 10

28%

Professor / Associate Prof. 5

14%

Readers' Discipline

Tooltip

Medicine and Dentistry 17

46%

Agricultural and Biological Sciences 9

24%

Biochemistry, Genetics and Molecular Bi... 7

19%

Pharmacology, Toxicology and Pharmaceut... 4

11%

Save time finding and organizing research with Mendeley

Sign up for free